Literature DB >> 3927238

Otologic symptoms and findings of the pseudotumor cerebri syndrome: a preliminary report.

A Sismanis, G B Hughes, E Abedi, G H Williams, L A Isrow.   

Abstract

Pseudotumor cerebri or benign intracranial hypertension is a syndrome characterized by increased intracranial pressure without focal signs of neurologic dysfunction. The clinical manifestations of this syndrome are usually headache and/or disturbance of vision. Although tinnitus, hearing loss, and vertigo have been described in association with intracranial hypertension, otologic symptomatology as the presenting manifestation of this syndrome has not been previously reported. In this article we report the otologic symptoms and findings of two pseudotumor cerebri patients, one of whom presented with pulsatile tinnitus. The pathogenesis of the otologic symptoms, diagnostic workup, and management of these patients are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 3927238     DOI: 10.1177/019459988509300321

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  4 in total

1.  Endovascular treatment of pulsatile tinnitus caused by dural sinus stenosis.

Authors:  J M Mathis; D Mattox; P Malloy; G Zoarski
Journal:  Skull Base Surg       Date:  1997

2.  Pulsatile tinnitus--a review of 84 patients.

Authors:  D Waldvogel; H P Mattle; M Sturzenegger; G Schroth
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

Review 3.  Idiopathic intracranial hypertension headache.

Authors:  Kathleen B Digre
Journal:  Curr Pain Headache Rep       Date:  2002-06

4.  Brain herniation (encephalocele) into arachnoid granulations: prevalence and association with pulsatile tinnitus and idiopathic intracranial hypertension.

Authors:  Eric R Smith; M Travis Caton; Javier E Villanueva-Meyer; Justin Remer; Laura B Eisenmenger; Amanda Baker; Vinil N Shah; Adelyn Tu-Chan; Karl Meisel; Matthew R Amans
Journal:  Neuroradiology       Date:  2022-03-25       Impact factor: 2.995

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.